Abiopharma

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

Ensysce Biosciences Expands Global Opioid Patent Portfolio

DuPont Schedules Fourth Quarter 2025 Earnings Conference Call

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

Genmab A/S (GNMSF) Files Form 6-K

(10% Negative) Johnson & Johnson (JNJ) Reports Q1 2026 Financial Results

Curaleaf Celebrates Launch of Adult-Use Sales in Maine at Bangor Dispensary

(90% Positive) enGene Inc (ENGNW) Provides Update on treatment for high-risk

(99% Neutral) Venus Concept Inc (VERO) Announces Business Combination

Agenus Inc. - Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™

Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC

Bausch Health Notification

Exicure, Inc. - Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings

QuidelOrtho Corporation - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results